International journal of clinical oncologyHumansQuality of LifeMaleFemaleAged
Longitudinal assessment of health-related quality of life, sleep quality, and gustation in patients with advanced urothelial carcinoma receiving late-line enfortumab vedotin monotherapy.
Makito Miyake, Nobutaka Nishimura, Yuki Oda, Takuto Shimizu, Takuya Owari, Kota Iida, Yasushi Nakai, Nobumichi Tanaka, Kiyohide Fujimoto
Published: 202610.1007/s10147-025-02953-5
Abstract
BACKGROUND: To describe real-world data on health-related quality of life (HRQoL) in patients with locally advanced or metastatic urothelial carcinoma receiving late-line enfortumab vedotin (EV) monotherapy. METHODS: This study included 19 previously…
Preview only. Read the full abstract at the source